{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:02:12Z","timestamp":1773792132353,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aims to evaluate the effect of Bacillus Calmette-Gu\u00e9rin (BCG) instillation and radical cystectomy on high-risk NMIBC with squamous or glandular variants. We retrospectively reviewed the data of high-risk (T1 or CIS or HG or TaG1\/G2 with multiple, recurrent, large tumor) NMIBC patients from January 2000 to December 2017. Comparative analysis of radical cystectomy, intravesical BCG, and observation groups was conducted in high-risk NMIBC with squamous or glandular histologic variants. Among the 1263 high-risk NMIBC patient, 62 (4.9%) were reported squamous or glandular histologic variants. Thirty patients underwent BCG instillation and 15 patients were subjected to radical cystectomy. Statistically significant differences were found between the three treatment groups in terms of underlying hypertension (p\u2009=\u20090.031), T stage (p\u2009=\u20090.022) and tumor multiplicity (p\u2009=\u20090.019). Similar 5-year OS (p\u2009=\u20090.893) and CSS (p\u2009=\u20090.811) were observed in each of BCG instillation and radical cystectomy group. BCG instillation showed survival benefit in both OS (p\u2009=\u20090.019) and CSS (p\u2009=\u20090.038) than in the observation group. In high-risk patients diagnosed with NMIBC bladder cancer with squamous or glandular histologic variants, both intravesical BCG and radical cystectomy showed survival gain. In conclusion, BCG instillation represents an appropriate treatment option in high-risk NMIBC with squamous or glandular histologic variant.<\/jats:p>","DOI":"10.1038\/s41598-019-51889-0","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T12:20:45Z","timestamp":1572006045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["BCG instillation versus radical cystectomy for high-risk NMIBC with squamous\/glandular histologic variants"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3867-4778","authenticated-orcid":false,"given":"Jungyo","family":"Suh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Chul","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hyun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junghoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Wook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Hoe","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0391-2342","authenticated-orcid":false,"given":"Ja Hyeon","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"51889_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni, S. et al. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur. Urol. 71, 96\u2013108 (2017).","journal-title":"Eur. Urol."},{"key":"51889_CR2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359\u2013E386 (2015).","journal-title":"Int. J. Cancer"},{"key":"51889_CR3","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.humpath.2006.05.009","volume":"37","author":"A Lopez-beltran","year":"2006","unstructured":"Lopez-beltran, A. & Cheng, L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum. Pathol. 37, 1371\u20131388 (2006).","journal-title":"Hum. Pathol."},{"key":"51889_CR4","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat, A. M. et al. Bladder cancer. Lancet 388, 2796\u20132810 (2016).","journal-title":"Lancet"},{"key":"51889_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.urolonc.2015.07.018","volume":"33","author":"LL Gellert","year":"2015","unstructured":"Gellert, L. L., Warrick, J. & Al-Ahmadie, H. A. Urothelial carcinoma with squamous differentiation-The pathologists\u2019 perspective. Urol. Oncol. Semin. Orig. Investig. 33, 437\u2013443 (2015).","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"51889_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5489\/cuaj.1195","volume":"3","author":"V Chalasani","year":"2009","unstructured":"Chalasani, V., Chin, J. L. & Izawa, J. I. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can. Urol. Assoc. J. 3, 193\u2013198 (2009).","journal-title":"Can. Urol. Assoc. J."},{"key":"51889_CR7","first-page":"1","volume":"9","author":"YJ Lee","year":"2014","unstructured":"Lee, Y. J. et al. Impact of squamous and glandular differentiation on oncologic outcomes in upper and lower tract urothelial carcinoma. PLoS One 9, 1\u20138 (2014).","journal-title":"PLoS One"},{"key":"51889_CR8","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.urolonc.2012.04.009","volume":"31","author":"RB Shah","year":"2013","unstructured":"Shah, R. B., Montgomery, J. S., Montie, J. E. & Kunju, L. P. Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital. Urol. Oncol. 31, 1650\u20131655 (2013).","journal-title":"Urol. Oncol."},{"key":"51889_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bju.13760","volume":"119","author":"SL Woldu","year":"2017","unstructured":"Woldu, S. L., Bagrodia, A. & Lotan, Y. Guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 119, 371\u2013380 (2017).","journal-title":"BJU Int."},{"key":"51889_CR10","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.6004\/jnccn.2017.7027","volume":"15","author":"JI Warrick","year":"2017","unstructured":"Warrick, J. I. Clinical significance of histologic variants of bladder cancer. JNCCN J. Natl. Compr. Cancer Netw. 15, 1268\u20131274 (2017).","journal-title":"JNCCN J. Natl. Compr. Cancer Netw."},{"key":"51889_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0022-5347(05)00423-4","volume":"175","author":"AM Kamat","year":"2006","unstructured":"Kamat, A. M. et al. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J. Urol. 175, 881\u2013885 (2006).","journal-title":"J. Urol."},{"issue":"6","key":"51889_CR12","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1016\/j.clgc.2017.07.008","volume":"15","author":"Akinori Minato","year":"2017","unstructured":"Minato, A., Fujimoto, N. & Kubo, T. Squamous differentiation predicts poor response to cisplatin-based chemotherapy and unfavorable prognosis in urothelial carcinoma of the urinary bladder. Clin. Genitourin. Cancer, https:\/\/doi.org\/10.1016\/j.clgc.2017.07.008 (2017).","journal-title":"Clinical Genitourinary Cancer"},{"key":"51889_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk, M. et al. EAU Guidelines on Non\u2013Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur. Urol. 71, 447\u2013461 (2017).","journal-title":"Eur. Urol."},{"key":"51889_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.juro.2014.09.092","volume":"193","author":"DL Willis","year":"2016","unstructured":"Willis, D. L. et al. Outcomes in cT1 Micropapillary Bladder Cancer. J. Urol. 193, 1129\u20131134 (2016).","journal-title":"J. Urol."},{"key":"51889_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.urolonc.2014.03.008","volume":"32","author":"HZ Kaimakliotis","year":"2014","unstructured":"Kaimakliotis, H. Z. et al. Plasmacytoid variant urothelial bladder cancer: Is it time to update the treatment paradigm? Urol. Oncol. Semin. Orig. Investig. 32, 833\u2013838 (2014).","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"51889_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4081\/rt.2011.e22","volume":"3","author":"NK Shapur","year":"2011","unstructured":"Shapur, N. K. et al. Is radical cystectomy mandatory in every patient with variant histology of bladder cancer? Rare tumor 3, 67\u201370 (2011).","journal-title":"Rare tumor"},{"key":"51889_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2016.00043","volume":"6","author":"ON Gofrit","year":"2016","unstructured":"Gofrit, O. N. et al. The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer. Front. Oncol. 6, 1\u20135 (2016).","journal-title":"Front. Oncol."},{"key":"51889_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jjco\/hyy066","volume":"48","author":"W Yorozuya","year":"2018","unstructured":"Yorozuya, W. et al. Bacillus Calmette-Gu\u00e9rin may have clinical benefit for glandular or squamous differentiation in non-muscle invasive bladder cancer patients: retrospective multicenter study. Jpn. J. Clin. Oncol. 48, 661\u2013666 (2018).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"51889_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.juro.2009.02.116","volume":"182","author":"AZ Weizer","year":"2009","unstructured":"Weizer, A. Z. et al. Multiple Adverse Histological Features Increase the Odds of Under Staging T1 Bladder Cancer. J. Urol. 182, 59\u201365 (2009).","journal-title":"J. Urol."},{"key":"51889_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/MOU.0000000000000086","volume":"24","author":"T Seisen","year":"2014","unstructured":"Seisen, T., Comp\u00e9rat, E., L\u00e9on, P. & Roupret, M. Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection. Curr. Opin. Urol. 24, 524\u201331 (2014).","journal-title":"Curr. Opin. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51889-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:54:15Z","timestamp":1671288855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51889-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51889"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51889-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15268"}}